UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
ASH 2019 Update in MPN: Triple Negative ET, Ropeginterferon in PV & Fedratinib, Luspatercept and Emerging Epigenetic-based Therapies in Myelofibrosis
Login to view comments.
Click here to Login